These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 15654758

  • 1. Apolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins.
    Zhao Y, Thorngate FE, Weisgraber KH, Williams DL, Parks JS.
    Biochemistry; 2005 Jan 25; 44(3):1013-25. PubMed ID: 15654758
    [Abstract] [Full Text] [Related]

  • 2. Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice.
    Furbee JW, Sawyer JK, Parks JS.
    J Biol Chem; 2002 Feb 01; 277(5):3511-9. PubMed ID: 11719520
    [Abstract] [Full Text] [Related]

  • 3. Effect of lecithin:cholesterol acyltransferase on distribution of apolipoprotein A-IV among lipoproteins of human plasma.
    Bisgaier CL, Sachdev OP, Lee ES, Williams KJ, Blum CB, Glickman RM.
    J Lipid Res; 1987 Jun 01; 28(6):693-703. PubMed ID: 3611972
    [Abstract] [Full Text] [Related]

  • 4. In vivo contribution of LCAT to apolipoprotein B lipoprotein cholesteryl esters in LDL receptor and apolipoprotein E knockout mice.
    Furbee JW, Francone O, Parks JS.
    J Lipid Res; 2002 Mar 01; 43(3):428-37. PubMed ID: 11893779
    [Abstract] [Full Text] [Related]

  • 5. Haptoglobin binds the antiatherogenic protein apolipoprotein E - impairment of apolipoprotein E stimulation of both lecithin:cholesterol acyltransferase activity and cholesterol uptake by hepatocytes.
    Cigliano L, Pugliese CR, Spagnuolo MS, Palumbo R, Abrescia P.
    FEBS J; 2009 Nov 01; 276(21):6158-71. PubMed ID: 19758344
    [Abstract] [Full Text] [Related]

  • 6. In vitro transformation of apoA-I-containing lipoprotein subpopulations: role of lecithin:cholesterol acyltransferase and apoB-containing lipoproteins.
    Cheung MC, Wolf AC.
    J Lipid Res; 1989 Apr 01; 30(4):499-509. PubMed ID: 2502592
    [Abstract] [Full Text] [Related]

  • 7. Role of lecithin:cholesterol acyltransferase and apolipoprotein A-I in cholesterol esterification in lipoprotein-X in vitro.
    O K, Frohlich J.
    J Lipid Res; 1995 Nov 01; 36(11):2344-54. PubMed ID: 8656072
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
    Simonelli S, Tinti C, Salvini L, Tinti L, Ossoli A, Vitali C, Sousa V, Orsini G, Nolli ML, Franceschini G, Calabresi L.
    Biologicals; 2013 Nov 01; 41(6):446-9. PubMed ID: 24140107
    [Abstract] [Full Text] [Related]

  • 11. Preferential redistribution of lipoprotein-unassociated apoA-IV to an HDL subpopulation with a high degree of LCAT modification.
    Lefevre M, Goudey-Lefevre JC, Roheim PS.
    Lipids; 1989 Dec 01; 24(12):1035-8. PubMed ID: 2615570
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity.
    Sparks DL, Frank PG, Neville TA.
    Biochim Biophys Acta; 1998 Feb 16; 1390(2):160-72. PubMed ID: 9507105
    [Abstract] [Full Text] [Related]

  • 14. Discoidal complexes containing apolipoprotein E and their transformation by lecithin-cholesterol acyltransferase.
    Gong EL, Nichols AV, Weisgraber KH, Forte TM, Shore VG, Blanche PJ.
    Biochim Biophys Acta; 1989 Dec 18; 1006(3):317-28. PubMed ID: 2597674
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of human lecithin:cholesterol acyltransferase in cholesterol-fed rabbits: LDL metabolism and HDL metabolism are affected in a gene dose-dependent manner.
    Brousseau ME, Santamarina-Fojo S, Vaisman BL, Applebaum-Bowden D, Bérard AM, Talley GD, Brewer HB, Hoeg JM.
    J Lipid Res; 1997 Dec 18; 38(12):2537-47. PubMed ID: 9458277
    [Abstract] [Full Text] [Related]

  • 16. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.
    Kypreos KE, Zannis VI.
    Biochem J; 2007 Apr 15; 403(2):359-67. PubMed ID: 17206937
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice.
    Vaisman BL, Klein HG, Rouis M, Bérard AM, Kindt MR, Talley GD, Meyn SM, Hoyt RF, Marcovina SM, Albers JJ.
    J Biol Chem; 1995 May 19; 270(20):12269-75. PubMed ID: 7744879
    [Abstract] [Full Text] [Related]

  • 18. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
    Koukos G, Chroni A, Duka A, Kardassis D, Zannis VI.
    Biochemistry; 2007 Sep 18; 46(37):10713-21. PubMed ID: 17711302
    [Abstract] [Full Text] [Related]

  • 19. Transgenic overexpression of human lecithin: cholesterol acyltransferase (LCAT) in mice does not increase aortic cholesterol deposition.
    Furbee JW, Parks JS.
    Atherosclerosis; 2002 Nov 18; 165(1):89-100. PubMed ID: 12208474
    [Abstract] [Full Text] [Related]

  • 20. Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins.
    Jin L, Shieh JJ, Grabbe E, Adimoolam S, Durbin D, Jonas A.
    Biochemistry; 1999 Nov 23; 38(47):15659-65. PubMed ID: 10569952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.